equityhold

ISRG

ISRG — thematic research focused on surgical robotics and the broader robotics narrative. We highlight a high-conviction view that advances in autonomy validate the humanoid and general-purpose robotics story, while noting timing and regulatory hurdles for revenue realization.

Opportunity
2 / 100
Current score
0.00
Thesis calls
1
Active ticker theses
1

Recent proof-backed thesis calls

No published buy/sell calls or analyst recommendations are on file for this ticker.

arXiv cs.LGrsswrong

Scientific paper proposes a unified benchmark (60 healthy subjects, 3 cadences) to predict hip muscle forces and joint moments directly from gait kinematics using sequence models; Transformer performed best and showed only moderate zero-shot generalization to a small external pathological cohort (9 ONFH patients). Investable implication is not the specific model, but acceleration/automation of gait analytics and biomechanics-derived metrics from cheaper kinematics inputs (wearables/markerless ca

Mentioned: Jun 1, 2026, 12:00 AM EDTConviction: 26 / 100Return: -7.69%
Source: Gait2Hip-60: A Unified Deep Learning Benchmark for Predicting Hip Muscle Forces and Joint Moments from Multi-Cadence Gait Kinematics

Current stance

No active recommendation is published for ISRG at this time.

Recommendationhold
Authors1
Active ticker theses1
Latest pricen/a
Why now
  • hold via Humanoid and general-purpose robotics narrative receives validation, but revenue timing remains uncertain. from https://www.youtube.com/@ycombinator (confidence 0.38)

Top authors on this asset

Active and historical ticker theses

Active play: 'The GPT Moment for Robotics Is Here' — argues that progress toward humanoid and general-purpose robotics is gaining validation, but revenue timing is uncertain.

Unlock full asset monitoring

Follow this page for updates on thematic research and any future recommendations related to ISRG and the robotics narrative.